Low TGF-β1 plasma levels are associated with cognitive decline in Down syndrome.
- DOI
- 10.3389/fphar.2024.1379965
- Published
- 2024
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2024.1379965,
title = {Low TGF-β1 plasma levels are associated with cognitive decline in Down syndrome.},
author = {Grasso M and Fidilio A and L'Episcopo F and Recupero M and Barone C and Bacalini MG and Benatti C and Giambirtone MC and Caruso G and Greco D and Di Nuovo S and Romano C and Ferri R and Buono S and Cuello AC and Blom JMC and Tascedda F and Piazza PV and De La Torre R and Caraci F},
year = {2024},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2024.1379965},
url = {https://doi.org/10.3389/fphar.2024.1379965}
}RIS
TY - JOUR TI - Low TGF-β1 plasma levels are associated with cognitive decline in Down syndrome. AU - Grasso M AU - Fidilio A AU - L'Episcopo F AU - Recupero M AU - Barone C AU - Bacalini MG AU - Benatti C AU - Giambirtone MC AU - Caruso G AU - Greco D AU - Di Nuovo S AU - Romano C AU - Ferri R AU - Buono S AU - Cuello AC AU - Blom JMC AU - Tascedda F AU - Piazza PV AU - De La Torre R AU - Caraci F PY - 2024 JO - Frontiers in pharmacology DO - 10.3389/fphar.2024.1379965 UR - https://doi.org/10.3389/fphar.2024.1379965 ER -
APA
M, G., A, F., F, L., M, R., C, B., MG, B., C, B., MC, G., G, C., D, G., S, D. N., C, R., R, F., S, B., AC, C., JMC, B., F, T., PV, P., R, D. L. T., & F, C. (2024). Low TGF-β1 plasma levels are associated with cognitive decline in Down syndrome.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2024.1379965
Source records
- pubmed · retrieved 2026-09-26T15:54:11.777Z